C-reactive protein and cardiovascular disease in people with diabetes

被引:16
作者
Xu, Yin [1 ]
Whitmer, Kyra
机构
[1] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA
[2] Univ Cincinnati, Inst Nursing Res, Cincinnati, OH USA
关键词
D O I
10.1097/00000446-200608000-00027
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
OVERVIEW. Having both diabetes and an elevated C-reactive protein (CRP) level compounds one's risk of developing cardiovascular disease, for which people with diabetes are at particularly high risk. CRP is both a biomarker for infectious and noninfectious disorders associated with inflammation and a risk factor for such conditions. Many researchers now believe that the protein also plays a role in the disease processes. The American Heart Association and the Centers for Disease Control and Prevention recently defined three cardiovascular risk categories relative to CRP levels. This article reviews the relevant literature and explores how CRP levels can be used in cardiovascular disease risk assessment, prevention, and treatment.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 45 条
  • [41] Weight loss reduces C-reactive protein levels in obese postmenopausal women
    Tchernof, A
    Nolan, A
    Sites, CK
    Ades, PA
    Poehlman, ET
    [J]. CIRCULATION, 2002, 105 (05) : 564 - 569
  • [42] C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men -: Results from the MONICA Augsburg Cohort Study, 1984-1998
    Thorand, B
    Löwel, H
    Schneider, A
    Kolb, H
    Meisinger, C
    Fröhlich, M
    Koenig, W
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (01) : 93 - 99
  • [43] Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging
    Tracy, RP
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) : S29 - S34
  • [44] Generation of C-reactive protein and complement components in atherosclerotic plaques
    Yasojima, K
    Schwab, C
    McGeer, EG
    McGeer, PL
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) : 1039 - 1051
  • [45] Zwaka TP, 2001, CIRCULATION, V103, P1194